Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.332NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.38.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.76NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.6.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.1.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.5.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.513NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.338NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.284NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.9.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.498NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.184NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.187NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
D.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.110.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.342NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.500NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.511NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.428.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.506NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20641US
B.1.482NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.335NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.499.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used